Education
About Us
Working with TipRanks
Follow Us
Immunovant (IMVT)
NASDAQ:IMVT
Immunovant (IMVT) Ownership Overview
2.73% Insiders
15.46% Mutual Funds
24.73% Other Institutional Investors
7.86% ETFs
49.22% Public Companies and
Individual Investors
The ownership structure of Immunovant (IMVT) stock is a mix of institutional, retail, and individual investors. Approximately 48.05% of the company’s stock is owned by Institutional Investors, 2.73% is owned by Insiders, and 49.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 21, 2025 | xxxxxxxxxxxxx | $42867 | |
| Feb 21, 2025 | Peter Salzmann Director | xxxxxxxxxxxxx | $322058 |
| Feb 21, 2025 | xxxxxxxxxxxxx | $58700 | |
| Jan 24, 2025 | Jay S Stout Cto | xxxxxxxxxxxxx | $51780 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $5011540 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $15920323 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $34858573 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $42304212 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 96,650,341 | Insider | 56.90% | 1,886,614,656 | |
| 6,467,832 | Institution | 3.81% | 126,252,081 | |
| 5,879,977 | Institution | 3.46% | 114,777,151 | |
| 5,539,942 | Institution | 3.26% | 108,139,668 | |
| 2,870,427 | Institution | 1.69% | 56,030,735 | |
| 2,139,199 | Institution | 1.26% | 41,757,164 | |
| 2,052,193 | Institution | 1.21% | 40,058,807 | |
| 1,707,881 | Institution | 1.01% | 33,337,837 | |
| 1,407,290 | Institution | 0.83% | 27,470,301 | |
| 1,332,383 | Institution | 0.78% | 26,008,116 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,879,977 | Institution | 3.46% | 114,777,151 | |
| 5,539,942 | Institution | 3.26% | 108,139,668 | |
| 2,052,193 | Institution | 1.21% | 40,058,807 | |
| 1,089,037 | Institution | 0.64% | 21,258,002 | |
| 914,442 | Institution | 0.54% | 17,849,908 | |
| 665,621 | Institution | 0.39% | 12,992,922 | |
| 642,615 | Institution | 0.38% | 12,543,845 | |
| 636,635 | Institution | 0.37% | 12,427,115 | |
| 510,490 | Institution | 0.30% | 9,964,765 | |
| 466,900 | Institution | 0.27% | 9,113,888 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,088,072 | Institution | 1.23% | 43,014,283 | |
| 1,682,053 | Institution | 0.99% | 41,664,453 | |
| 1,570,452 | Institution | 0.92% | 30,655,223 | |
| 1,218,292 | Institution | 0.72% | 22,891,707 | |
| 1,108,724 | Institution | 0.65% | 22,839,714 | |
| 1,006,461 | Institution | 0.59% | 20,733,097 | |
| 515,587 | Institution | 0.30% | 10,064,258 | |
| 422,517 | Institution | 0.25% | 8,247,532 | |
| 308,815 | Institution | 0.18% | 5,802,634 | |
| 265,956 | Institution | 0.16% | 5,478,694 |
FAQ
Who Owns Immunovant (IMVT)?
According to the latest TipRanks data, approximately 24.73% of the company's stock is held by institutional investors, 2.73% is held by insiders, and 49.22% is held by retail investors.
What percentage of Immunovant (IMVT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.73% of Immunovant (IMVT) stock is held by institutional investors.
What percentage of Immunovant (IMVT) stock is held by retail investors?
According to the latest TipRanks data, approximately 49.22% of Immunovant (IMVT) stock is held by retail investors.
Who owns the most shares of Immunovant (IMVT)?
Roivant Sciences Ltd. owns the most shares of Immunovant (IMVT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.